A 100% human milk-based fortifier from Prolacta® Bioscience
Clinicians
For more than two decades, Prolacta has been the world’s leading hospital provider of 100% human milk-based nutritional products that help adequately feed critically ill, premature infants so that they can grow and thrive. Now we’re bringing the power of human milk to term infants who are recovering from surgery – helping them achieve targeted growth with reduced risk of complications. 1
After an infant undergoes surgery, nothing nurtures like an exclusive human milk diet
Prolacta's human milk-based fortifiers, when used as part of an Exclusive Human Milk Diet, have been shown in more than 20 peer- review studies to improve health outcomes and reduce the most serious complications of prematurity.2,3,4,5,6,7,8
While term infants requiring surgery and premature infants represent different groups of neonates, they share common challenges of poor growth and significant morbidities when a cow milk-based nutritional fortifier is used.9,8 Safe and early post- surgical fortification helps address feeding challenges in these infants.1
A study with Surgifort® found that infants recovering from surgery have improved weight gain, decreased growth failure at discharge and decreased complications such necrotizing enterocolitis when fed with an Exclusive Human Milk Diet.1
Nutrition information
For the difference-making nutritional content that Surgifort fortifier provides to term infants, consult the product nutrition information.
Exclusive Human Milk Diet (EHMD) Feeding Protocol
Prior to Surgifort there wasn’t a consistent feeding protocol for term infants post-surgery.9,10 A standardized EHMD feeding protocol provides guidance to ensure optimal caloric intake to meet each infant’s nutritional needs and growth goals. Reach out to us for clinician-to-clinician orientation.
Already using SURGIFORT? These resources are for you.
Here is where you will find product preparation instructions and supplementary information.
Prolacta Clinical Advisory Board (PCAB)
Prolacta’s Clinical Advisory Board is a group of multidisciplinary clinicians who are passionate about human milk science and nutrition. After witnessing first-hand the improved patient outcomes of an Exclusive Human Milk Diet (EHMD), our mission is to share clinical expertise and emerging research, thereby enhancing clinical practice, education, and outcomes in critically ill infants and other vulnerable patients.